Acute national research infrastructure for collecting blood samples for COVID-19,
- Funded by Novo Nordisk Foundation
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AKnown Financial Commitments (USD)
$577,280Funder
Novo Nordisk FoundationResearch Location
DenmarkLead Research Institution
Statens Serum InstitutResearch Priority Alignment
N/A
Research Category
Health Systems ResearchResearch Subcategory
Medicines, vaccines & other technologiesSpecial Interest Tags
Digital HealthStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
The project will establish an immediate, broad and national COVID-19 collaboration over the next six months, in order to collect diagnostic blood samples from hospitals across all of Denmark. The purpose is to build a unique research infrastructure with 500,000 biological samples from all types of patients, including patients with very early stages of COVID-19 infection, patients with acute and life-threatening infections and patients who have recovered from the infection. All biological samples will be made available, free of charge, for COVID-19-related research projects within the next two years.